Mutational analysis of ETV6 in prostate carcinoma

Prostate

Volumn 52, Issue 4, 2002, Pages 305-310

  Kibel, Adam S ^a   Faith, Dennis A ^b   Bova, G Steven ^b   Isaacs, William B ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

DNA; ETV6; Neoplasm analysis; Prostatic neoplasms; Tel

Indexed keywords

CELL DNA;

ARTICLE; CANCER CELL CULTURE; CHROMOSOME 12P; CLINICAL ARTICLE; CONTROLLED STUDY; DNA ISOLATION; DNA POLYMORPHISM; ETV6 GENE; GEL ELECTROPHORESIS; GENE DELETION; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN CELL; MALE; METASTASIS; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CARCINOMA; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE; XENOGRAFT;

CARCINOMA; DNA MUTATIONAL ANALYSIS; DNA PRIMERS; DNA-BINDING PROTEINS; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; NEOPLASM METASTASIS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-ETS; REPRESSOR PROTEINS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0036721375     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.10112     Document Type: Article

References (29)

1. Cancer statistics, 2000
2. Identification of 12p as a region of frequent deletion in advanced prostate cancer
3. Loss of heterozygosity at 12P12-13 in primary and metastatic prostate adenocarcinoma
4. Tumor suppressor genes
5. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma
6. A cell cycle regulator potentially involved in genesis of many tumor types
7. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer
8. A tumor chromosome rearrangement further defines the 11p13 Wilms tumor locus
9. Methylation and mutational analysis of p27(kip1) in prostate carcinoma
10. Deletion mapping at 12p12-13 in metastatic prostate cancer
11. Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation
12. The novel activation of ABL by fusion to an ets-related gene, TEL
13. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia
14. Translocation (12;22) (p13;q11) in myeloproliferative disorders results in fusion of the ETS-like TEL gene on 12p13 to the MN1 gene on 22q11
15. A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia
16. A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma
17. Characterization of a novel androgen-sensitive, prostate-specific antigen-producing prostatic carcinoma xenograft: LuCaP 23
18. Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice
19. CWR22: The first human prostate cancer xenograft with strongly androgen-dependent and relapsed strains both in vivo and in soft agar
20. Xenografts of primary human prostatic carcinoma
21. Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer
22. Genomic organization of TEL: The human ETS-variant gene 6
23. Mutational analysis of the candidate tumor suppressor genes TEL and KIP1 in childhood acute lymphoblastic leukemia
24. The TEL/ETV6 gene is required specifically for hematopoiesis in the bone marrow
25. Yolk sac angiogenic defect and intra-embryonic apoptosis in mice lacking the Ets-related factor TEL
26. Frequent deletion of chromosome 12p12.3 in children with acute lymphoblastic leukaemia
27. The TEL gene products: Nuclear phosphoproteins with DNA binding properties
28. The ets family member Tel binds to the Fli-1 oncoprotein and inhibits its transcriptional activity
29. Modulation of TEL transcription activity by interaction with the ubiquitin-conjugating enzyme UBC9